Department Blog

Posted 5/3/2017 by Linda Kesselring

Dr. Bond Appointed to CORD Board of Directors

Michael Bond, MD, our Residency Program Director, has been appointed as a member-at-large on the Board of Directors of the Council of Residency Directors in Emergency Medicine. The announcement was made during the organization’s annual Academic Assembly, held last week in Fort Lauderdale.


Posted 4/19/2017 by Linda Kesselring

The Power of a Question

Laura J. Bontempo, MD, MEd, published “Family Medical History” in the Reflections column of Academic Emergency Medicine (24[2]:254-255, February 2017). In this pensive essay, Dr. Bontempo examines the impact of a question asked by many practitioners during their initial assessment of a patient. Routine inquiry into the family’s medical history becomes much less routine when heard from the patient's point of view.


Posted 4/17/2017 by Linda Kesselring

Pain Management for Sickle Cell Crisis

Amani Mahdi, MD, MBBS, former emergency medicine research fellow, published "Pain Management in Vaso-occlusive Sickle Cell Crisis" in EMResident this month. Her article is available at www.emresident.org/sickle-cell-crisis/.


Posted 4/6/2017 by Linda Kesselring

New ACEP Policy on Psychiatric Care

The American College of Emergency Physicians has issued a new policy on the diagnosis and management of adult psychiatric patients in EDs, available in the April issue of Annals of Emergency Medicine (69[4]:480-498). Jon Mark Hirshon, MD, MPH, PhD, is a member of ACEP's Clinical Policies Committee, which oversaw the development of the document.


Posted 4/4/2017 by Linda Kesselring

Dr. Sward Teaches Search and Rescue

Doug Sward, MD, presented a workshop during the Wilderness and Disaster Medicine course at the University of Pennsylvania Perelman School of Medicine in early March. Titled “Search and Rescue: Initial Tasks and Reflex Actions,” his didactic presentation reviewed lost-person behavior and its application to rescue missions and was followed by a hands-on exercise that asked students to develop a search strategy using a topographic map. The 2-week course encourages students to improvise under austere conditions and prepares them to respond to emergencies in wilderness settings as well as disaster scenarios. A Wall Street Journal article about the course can be read here: https://www.wsj.com/articles/latest-medical-school-trend-wilderness-training-1490097604?emailToken=JRryd/96aHqXgdY1b8w43UEldbVNDuKFR1jeKDXRMUjLs3iQvfiswalwmNqzrW61Q0th/JUY9Wc+QzzXjy8zAJ7Jw+8gzw/4


Posted 3/30/2017 by Linda Kesselring

Mediation of Neuroinflammation after TBI

Ming Yang, MD, and Stephen Thom, MD, PhD, collaborated with colleagues from the Department of Anesthesiology and the Shock, Trauma and Anesthesiology Research (STAR) Center (Alok Kumar, PhD, Bogdan Stoica, MD, David Loane, PhD, Gelareh Abulwerdi, Niaz Khan, Asit Kumar, PhD, and Alan Faden, MD) on the study that culminated in the article titled “Microglia-Derived Microparticles Mediate Neuroinflammation After Traumatic Brain Injury,” published in the March issue of the Journal of Neuroinflammation.


Posted 3/28/2017 by Linda Kesselring

Anomaly Detection Predicts Trauma Patient Outcomes

Zachary D.W. Dezman, MD, MS, in collaboration with Cheng Gao, PhD, Hsiao-Chi Li, PhD, Shiming Yang, PhD, Peter Hu, PhD, and Colin F. Mackenzie, MBChB, in the Shock Trauma Anesthesiology Research Center, Department of Anesthesiology, and with Yao Li, MS, and Chein-I Chang, PhD, from the Remote Sensing Signal and Image Processing Laboratory, Department of Computer Science and Electrical Engineering at UMBCpublished the article titled “Anomaly Detection Outperforms Logistic Regression in Predicting Trauma Patient Outcomes” in the March/April issue of Prehospital Emergency Care (21[2]:174?179). Their study was based on the records of 5464 patients seen at Shock Trauma in 2009 and 2010. Anomaly detection and logistic regression were equally capable of predicting the need for massive transfusion, but anomaly decision significantly outperformed logistic regression in identifying patients who would receive uncrossmatched blood, who would receive a transfusion within 6 hours after admission, who would need intensive care, and who were most likely to die during hospitalization.


Posted 3/13/2017 by Linda Kesselring

Case Report: ACE Inhibitor Angioedema Worsened by FFP

A case report by Omoyemi Adebayo, MD, and R. Gentry Wilkerson, MD, was published in The American Journal of Emergency Medicine in January (35[1]:192.e1?192.e2). Its title is “Angiotensin-Converting Enzyme Inhibitor?Induced Angioedema Worsened with Fresh Frozen Plasma.”


Posted 3/8/2017 by Linda Kesselring

CPC Column in New Journal

Zachary Dezman, MD, and Laura Bontempo, MD, have been named co-editors of a column in a new journal, Clinical Practice and Cases in Emergency Medicine. Their column, Clinicopathological Cases from the University of Maryland, features descriptions of real patients, with difficult diagnoses, who were assessed and treated in our ED. Based on the format used in CORD's Clinical Pathologic Case Presentation Competition, the articles begin with a resident’s detailed description of a patient’s presentation followed by an attending’s explanation of his or her thought process leading to the diagnosis and an educational section about the disease or condition. The first case report in this series is in the inaugural issue of CPC-EM. Drs. Bontempo and Dezman, in collaboration with Danya Khoujah, MBBS, and Andrew Crouter, MD, present their assessment of an "18-Year-Old Female with a Change in Mental Status” (1:3?8, March 2017).

 


Posted 2/28/2017 by Linda Kesselring

Study of Rivipansel for Sickle Cell Disease

R. Gentry Wilkerson, MD, has received a grant from Pfizer, Inc., to evaluate the efficacy and safety of rivipansel in the treatment of vaso-occlusive crisis in hospitalized patients with sickle cell disease. Rivipansel is a new drug that reduces cell adhesion and inflammation and therefore could have a variety of clinical applications. Dr. Wilkerson’s multicenter trial will test its ability to improve blood flow in people with sickle cell disease and thus alleviate their pain. The grant is in the amount of $342,232.